Friday, July 31, 2026 | 12:27 PM ISTहिंदी में पढें
Akshat Ayush
Akshat Ayush
Akshat Ayush
Akshat Ayush
Page 2 - Akshat Ayush
Piramal Pharma shares rise 4% on successful closure of US FDA inspection
Piramal Pharma said that the US FDA has issued an Establishment Inspection Report (EIR) for its Sellersville facility, and the inspection has now been successfully closed.
 "Piramal Pharma shares rise 4% on successful closure of US FDA inspection")
Updated On : 09 Jul 2026 | 3:16 PM IST
Q1FY27 aviation preview: Analysts advise watching crude and rupee impact
Q1FY27 aviation preview: Key monitorables, Elara Capital said, are the extent of impact on international operations and rise in fuel/non-fuel costs from lower aircraft utilisation & rupee weakening
 "Q1FY27 aviation preview: Analysts advise watching crude and rupee impact")
Updated On : 09 Jul 2026 | 7:41 AM IST
Nomura retains 'buy' on Uno Minda amid expansion plans, sees 33% upside
The company had been manufacturing seat recliners since 2022, but is now expanding to manufacture complete seating systems.
 "Nomura retains 'buy' on Uno Minda amid expansion plans, sees 33% upside")
Updated On : 08 Jul 2026 | 10:14 AM IST
Eternal stock up 2%; Motilal Oswal retains buy for 31% upside
Motilal Oswal Financial Services has reiterated its 'Buy' rating on Eternal stock for a target price of ₹380, implying an upside of 31 per cent from its current price.
 "Eternal stock up 2%; Motilal Oswal retains buy for 31% upside")
Updated On : 07 Jul 2026 | 3:54 PM IST